A Health Survey-Based Prediction Equation for Incident CKD.
Journal
Clinical journal of the American Society of Nephrology : CJASN
ISSN: 1555-905X
Titre abrégé: Clin J Am Soc Nephrol
Pays: United States
ID NLM: 101271570
Informations de publication
Date de publication:
01 01 2023
01 01 2023
Historique:
received:
12
05
2022
accepted:
17
10
2022
pmc-release:
01
01
2024
entrez:
31
1
2023
pubmed:
1
2
2023
medline:
3
2
2023
Statut:
ppublish
Résumé
Prediction tools that incorporate self-reported health information could increase CKD awareness, identify modifiable lifestyle risk factors, and prevent disease. We developed and validated a survey-based prediction equation to identify individuals at risk for incident CKD (eGFR <60 ml/min per 1.73 m2), with and without a baseline eGFR. A cohort of adults with an eGFR ≥70 ml/min per 1.73 m2 from Ontario, Canada, who completed a comprehensive general population health survey between 2000 and 2015 were included (n=22,200). Prediction equations included demographics (age, sex), comorbidities, lifestyle factors, diet, and mood. Models with and without baseline eGFR were derived and externally validated in the UK Biobank (n=15,522). New-onset CKD (eGFR <60 ml/min per 1.73 m2) with ≤8 years of follow-up was the primary outcome. Among Ontario individuals (mean age, 55 years; 58% women; baseline eGFR, 95 (SD 15) ml/min per 1.73 m2), new-onset CKD occurred in 1981 (9%) during a median follow-up time of 4.2 years. The final models included lifestyle factors (smoking, alcohol, physical activity) and comorbid illnesses (diabetes, hypertension, cancer). The model was discriminating in individuals with and without a baseline eGFR measure (5-year c-statistic with baseline eGFR: 83.5, 95% confidence interval [CI], 82.2 to 84.9; without: 81.0, 95% CI, 79.8 to 82.4) and well calibrated. In external validation, the 5-year c-statistic was 78.1 (95% CI, 74.2 to 82.0) and 66.0 (95% CI, 61.6 to 70.4), with and without baseline eGFR, respectively, and maintained calibration. Self-reported lifestyle and health behavior information from health surveys may aid in predicting incident CKD. This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast.aspx?p=CJASN&e=2023_01_10_CJN05650522.mp3.
Sections du résumé
BACKGROUND
Prediction tools that incorporate self-reported health information could increase CKD awareness, identify modifiable lifestyle risk factors, and prevent disease. We developed and validated a survey-based prediction equation to identify individuals at risk for incident CKD (eGFR <60 ml/min per 1.73 m2), with and without a baseline eGFR.
METHODS
A cohort of adults with an eGFR ≥70 ml/min per 1.73 m2 from Ontario, Canada, who completed a comprehensive general population health survey between 2000 and 2015 were included (n=22,200). Prediction equations included demographics (age, sex), comorbidities, lifestyle factors, diet, and mood. Models with and without baseline eGFR were derived and externally validated in the UK Biobank (n=15,522). New-onset CKD (eGFR <60 ml/min per 1.73 m2) with ≤8 years of follow-up was the primary outcome.
RESULTS
Among Ontario individuals (mean age, 55 years; 58% women; baseline eGFR, 95 (SD 15) ml/min per 1.73 m2), new-onset CKD occurred in 1981 (9%) during a median follow-up time of 4.2 years. The final models included lifestyle factors (smoking, alcohol, physical activity) and comorbid illnesses (diabetes, hypertension, cancer). The model was discriminating in individuals with and without a baseline eGFR measure (5-year c-statistic with baseline eGFR: 83.5, 95% confidence interval [CI], 82.2 to 84.9; without: 81.0, 95% CI, 79.8 to 82.4) and well calibrated. In external validation, the 5-year c-statistic was 78.1 (95% CI, 74.2 to 82.0) and 66.0 (95% CI, 61.6 to 70.4), with and without baseline eGFR, respectively, and maintained calibration.
CONCLUSIONS
Self-reported lifestyle and health behavior information from health surveys may aid in predicting incident CKD.
PODCAST
This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast.aspx?p=CJASN&e=2023_01_10_CJN05650522.mp3.
Identifiants
pubmed: 36720027
doi: 10.2215/CJN.0000000000000035
pii: 01277230-202301000-00008
pmc: PMC10101574
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
28-35Informations de copyright
Copyright © 2023 by the American Society of Nephrology.
Références
Epidemiology. 2009 Jul;20(4):555-61
pubmed: 19367167
J Epidemiol Community Health. 2021 Sep;75(9):843-853
pubmed: 34172513
N Engl J Med. 2021 Nov 4;385(19):1737-1749
pubmed: 34554658
J Am Soc Nephrol. 2009 Dec;20(12):2625-30
pubmed: 19892934
Am J Kidney Dis. 2008 Aug;52(2):382-3
pubmed: 18640489
Am J Kidney Dis. 2014 May;63(5):789-97
pubmed: 24529536
Am J Kidney Dis. 2015 Mar;65(3):412-24
pubmed: 25458663
Exp Gerontol. 2017 Jan;87(Pt B):153-155
pubmed: 27032877
Ann Intern Med. 2015 Jan 6;162(1):55-63
pubmed: 25560714
Stat Med. 2014 Feb 10;33(3):517-35
pubmed: 24002997
Am J Kidney Dis. 2006 Mar;47(3):396-405
pubmed: 16490617
BMC Fam Pract. 2010 Jun 21;11:49
pubmed: 20565929
Epidemiology. 2010 Jan;21(1):128-38
pubmed: 20010215
J Am Soc Nephrol. 2005 May;16(5):1433-9
pubmed: 15800126
Am J Kidney Dis. 2018 Jun;71(6):842-850
pubmed: 29198643
Clin J Am Soc Nephrol. 2019 Oct 7;14(10):1441-1449
pubmed: 31551237
Curr Opin Nephrol Hypertens. 2012 Nov;21(6):612-8
pubmed: 23042027
J Am Soc Nephrol. 2006 Jul;17(7):2034-47
pubmed: 16738019
CMAJ. 2018 Jul 23;190(29):E871-E882
pubmed: 30037888
Can J Kidney Health Dis. 2020 Feb 11;7:2054358120903156
pubmed: 32110417
Am J Kidney Dis. 2016 Jul;68(1):29-40
pubmed: 26830448
JAMA. 2002 Nov 20;288(19):2469-75
pubmed: 12435261
J Clin Epidemiol. 2001 Aug;54(8):774-81
pubmed: 11470385
Can J Psychiatry. 2005 Sep;50(10):573-9
pubmed: 16276847
Clin J Am Soc Nephrol. 2017 Jul 7;12(7):1181-1189
pubmed: 28242844
Stat Med. 2002 Dec 30;21(24):3803-22
pubmed: 12483768
BMJ. 2021 Sep 28;374:n2134
pubmed: 34583929
Am J Kidney Dis. 2005 Dec;46(6):1088-98
pubmed: 16310575
Stat Methods Med Res. 1999 Mar;8(1):3-15
pubmed: 10347857
Lancet. 2013 Jul 20;382(9888):260-72
pubmed: 23727169
CMAJ. 2019 Jan 28;191(4):E115
pubmed: 30692114
JAMA. 2014 Jun 25;311(24):2518-2531
pubmed: 24892770
Adv Chronic Kidney Dis. 2010 May;17(3):225-36
pubmed: 20439091